Sorrento Therapeutics
Manufacturing · California, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
9380 Judicial Dr, San Diego, California,...Website
www.sorrentotherapeutics.comRevenue
$60.3 MillionStock Symbol
SRNEIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Sorrento Therapeutics
Founded in 1989, Sorrento Therapeutics is a clinical-stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers. The company is headquartered in San Diego, California.Explore more
Sorrento Therapeutics Org Chart
Get the full picture
Sign in to uncover key details.
Show More
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sorrento Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Sorrento Therapeutics is spiking on competitors!
Earning: See what the market has to say on Sorrento Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Sorrento Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Sorrento Therapeutics
Sorrento Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Sorrento Therapeutics has new funding data
Product Launch: Get notified when Sorrento Therapeutics launches new products
Check if Sorrento Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Reach out to Masked Content who joined Sorrento Therapeutics as Masked Content
Find 2 more new buyers
Compare Similar Companies to Sorrento Therapeutics
Compare insights from companies similar to Sorrento Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Sorrento Therapeutics
$60.3M
501-1,000
Public
$685M
1989
Scott SchausChief Technology Officer, Diagnostics
Company Profile Activity
Activity Insights
Sorrento Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sorrento Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sorrento Therapeutics.
Sorrento Therapeutics financials insights
Gather financial insights about Sorrento Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Unspecified
$6.5M
Debt
$1.9M
2016
Multiple Rounds
$235M
2017
Stock Offering
$43.5M
2018
Debt
$120.5M
Debt
$150M
2019
Stock Offering
$23.1M
Stock Offering
$23.3M
2020
Debt
$2M
2023
Debt
$75M
Sorrento Therapeutics Tech Stack
A closer look at the technologies used by Sorrento Therapeutics
See more technologies
Most Recent Scoops
Left Company
Executive Move
Left Company
Executive Move
Funding
Pain Point
Bankruptcy
Project
Accounting, Financial Planning, Billing & Invoice
Sorrento Therapeutics News & Media
Sorrento Shareholders Sue CEO, Jackson Walker Over Bankruptcy - Bloomberg Law News
Sorrento Therapeutics Inc. shareholders sued the company’s CEO, its bankruptcy counsel Jackson Walker LLP, and its restructuring professionals, accusing them of fabricating a bogus connection to Texas to file its bankruptcy case there.Sorrento Therapeutics Trustee Sues Executives Over Bankruptcy - Bloomberg Law News
The liquidating trustee for Sorrento Therapeutics sued former directors and officers for breach of fiduciary duty, arguing their actions ignored the biopharmaceutical company’s financial state.Shopping Spree, My Own Prison, Aggregate Supply, and Bad Form | Seward & Kissel LLP
Latham, Jackson Walker Avoid Sanctions Over Bankruptcy Forum Shopping Dispute | Reuters - In a court hearing on Monday, U.S. Bankruptcy Judge Christopher Lopez in Houston ruled...Sorrento Therapeutics, Inc. Announces the Consummation of the Previously Announced Sale of Substantially All of the Common Shares, Preferred Shares and Warrants that Sorrento Held in Scilex Holding Company
SAN DIEGO, Sept. 22, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (OTC: SRNEQ, "Sorrento" or "Company"), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, announced the consummation on...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sorrento Therapeutics
Sign Up For FreeTo access detailed company insights
Founded in 1989, Sorrento Therapeutics is a clinical-stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers. The company is headquartered in San Diego, California.... Read More
